Linda Smith-Resar Lab

  • The Linda Smith-Resar Lab primarily investigates hematologic malignancy and molecular mechanisms that lead to cancer as well as sickle cell anemia. Recent studies suggest that education is an important and effective component of a patient blood management program and that computerized provider order entry algorithms may serve to maintain compliance with evidence-based transfusion guidelines. Another recent study indicated that colonic epithelial cells undergo metabolic reprogramming during their evolution to colorectal cancer, and the distinct metabolites could serve as diagnostic tools or potential targets in therapy or primary prevention.

    Research Areas: blood disorders, sickle cell diseases, blood management programs, hematologic malignancies

    Lab Website

    Principal Investigator

    Linda Smith-Resar, M.D.

    Department

    Medicine